Current treatment strategies for seasonal allergic rhinitis: where are we heading?
Erminia RidoloCristoforo IncorvaiaFrancesco PucciariniElena MakriGiovanni PaolettiGiorgio Walter CanonicaPublished in: Clinical and molecular allergy : CMA (2022)
Drug treatment of AR include a large number of agents, the choice of which depends on the severity of the disease. AIT has high evidence of efficacy demonstrated by meta-analyses, and further improvement is currently apparent, as for diagnosis, applying the means of precision medicine. However, when AIT is performed in current practice, without the strict rules of controlled trials, long-term low adherence is a major problem to be solved.